LEE GARY K. (Chief Scientific Officer) sold 0.9% of their position (138.00 shares) of LYELL IMMUNOPHARMA, INC. on the open market
Open‑market sale worth $2.2K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 11/12/2025ACC: 0001907345-25-000006
Officer· Chief Scientific Officer
Since Jan 2022
-138.00
Net shares
Net seller
$2.2K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
138.00 disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−138.00
Price / share
$16.16
Trade value
$2.23K
% of position
0.9%
11/10/2025
15.50K→15.37K
Total
Net shares
−138.00
Net value
-$2.23K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 11/10/2025 | S · Sale | −138.00 | $16.16 | $2.23K | 0.9% | 15.50K | 15.37K |
| Total | −138.00 | -$2.23K | ||||||
Derivative Transactions0
No derivative transactions reported